Recap: Pacira BioSciences Q1 Earnings


Pacira BioSciences PCRX reported its Q1 earnings results on Wednesday, May 3, 2023 at 08:00 AM.

Here's what investors need to know about the announcement.


Pacira BioSciences missed estimated earnings by 14.52%, reporting an EPS of $0.53 versus an estimate of $0.62.

Revenue was up $2.35 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 1.9% increase in the share price the next day.

Here's a look at Pacira BioSciences's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 0.83 0.76 0.88 0.83
EPS Actual 0.80 0.64 0.51 0.64
Revenue Estimate 173.50M 168.89M 171.43M 159.49M
Revenue Actual 171.96M 167.47M 169.41M 157.99M

To track all earnings releases for Pacira BioSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!